Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | -97.63%99K | 6.04%4.2M | 137.05%9.4K | -14.29%12K | -98.06%74.04K | 3,060.61%4.17M | 5.99%3.96M | -82.08%3.97K | -53.33%14K | 279.38%3.81M |
| Revenue from customers | -25.00%15K | --0 | 78.26%-40K | -14.29%12K | ---- | -84.85%20K | --0 | -159.15%-184K | -53.33%14K | ---- |
| Income from government grants | -97.98%84K | 10.44%4.16M | 129.78%3.36K | --0 | -98.24%66.41K | --4.15M | 2.92%3.76M | -204.41%-11.28K | --0 | 278.50%3.77M |
| Other cash income from operating activities | ---- | -76.89%46.04K | ---- | ---- | ---- | ---- | 142.04%199.25K | ---- | ---- | ---- |
| Cash paid | -45.82%-20.35M | -64.74%-69.93M | -126.14%-19.14M | -75.44%-17.08M | -103.60%-21.07M | 0.38%-13.96M | -6.14%-42.45M | -2.30%-8.46M | 32.36%-9.73M | -52.90%-10.35M |
| Payments to suppliers for goods and services | -67.11%-15.83M | -64.74%-69.93M | -61.64%-30.65M | -97.19%-13.59M | -74.58%-25.56M | 2.55%-9.47M | -6.14%-42.45M | -22.86%-18.96M | 40.19%-6.89M | -67.68%-14.64M |
| Cash paid on behalf of employees | -21.15%-3.36M | ---- | ---- | -24.63%-2.5M | ---- | -21.02%-2.78M | ---- | ---- | -20.41%-2.01M | ---- |
| Other cash payments from operating activities | 32.18%-1.16M | ---- | ---- | -17.99%-984K | ---- | 14.38%-1.71M | ---- | ---- | 30.50%-834K | ---- |
| Direct dividend received | --0 | ---- | ---- | --0 | ---- | --0 | ---- | ---- | --0 | ---- |
| Direct interest paid | 36.36%-7K | -18.45%-35.55K | -17.05%-10.55K | 20.00%-8K | 23.28%-5.97K | -266.67%-11K | -46.09%-30.01K | -178.62%-9.01K | -400.00%-10K | -154.62%-7.79K |
| Direct interest received | 1.58%1.22M | 0.56%3.72M | -7.39%905.33K | 9.16%810K | 10.55%1.05M | 17.27%1.2M | 302.57%3.7M | 133.32%977.59K | 278.57%742K | 423.05%950.72K |
| Direct tax refund paid | --0 | --0 | --0 | --0 | ---- | --0 | --0 | --0 | --0 | ---- |
| Operating cash flow | -121.54%-19.04M | -78.20%-62.05M | -143.43%-18.23M | -80.95%-16.26M | -256.60%-19.95M | 33.15%-8.59M | 1.51%-34.82M | 4.21%-7.49M | 36.56%-8.99M | -0.49%-5.6M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 209.40%35.46M | -83.33%-38.53M | 59.48%-8.12M | 5,885.69%32.34M | -37,382.57%-30.41M | -9,488.46%-32.41M | -25,304.82%-21.02M | -36,492.08%-20.03M | -55,800.00%-559K | -64.86%-81.12K |
| Net PPE purchase and sale | -400.00%-5K | -56.66%-45.77K | -408,394.51%-37.64M | 1,078,166.67%32.34M | -54.09%-10.5K | 90.00%-1K | 64.69%-29.22K | 76.21%-9.22K | -200.00%-3K | 89.58%-6.82K |
| Net intangibles purchas and sale | --0 | 75.04%-225.41K | 225.98%50.59K | --0 | -1,978.14%-225.41K | --0 | ---903.15K | ---40.15K | ---535K | --12K |
| Net business purchase and sale | --0 | ---- | ---- | --0 | ---- | --0 | ---- | ---- | --0 | ---- |
| Net investment purchase and sale | 209.42%35.46M | -90.49%-38.26M | 247.38%29.48M | --0 | -34,856.57%-30.17M | ---32.41M | ---20.09M | ---20M | --0 | ---86.31K |
| Dividends received (cash flow from investment activities) | --0 | ---- | ---- | --0 | ---- | --0 | ---- | ---- | --0 | ---- |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -10,347.76%-21K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 209.40%35.46M | -83.33%-38.53M | 59.48%-8.12M | 5,885.69%32.34M | -37,382.57%-30.41M | -9,488.46%-32.41M | -25,304.82%-21.02M | -36,492.08%-20.03M | -55,800.00%-559K | -64.86%-81.12K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 80.70%-72K | -100.55%-525.12K | -100.03%-33.12K | -18.18%-65K | 24.62%-54.17K | -3.61%-373K | 25.20%95.18M | 25.59%95.66M | -19.57%-55K | -13.73%-71.86K |
| Net issuance payments of debt | --0 | -19.50%-270.67K | -759.42%-270.67K | --0 | 8.22%-118.22K | --0 | -6.85%-226.49K | 49.18%-31.49K | -19.57%-55K | -103.88%-128.81K |
| Net common stock issuance | --0 | --0 | --0 | --0 | ---- | --0 | 25.16%100.24M | ---- | ---- | ---- |
| Cash dividends paid | --0 | ---- | ---- | --0 | ---- | --0 | ---- | ---- | --0 | ---- |
| Proceeds from stock option exercised by employees | --0 | ---- | ---- | --0 | ---- | --0 | ---- | ---- | --0 | ---- |
| Net other financing activities | 80.70%-72K | 94.73%-254.46K | 105.23%237.55K | -562.77%-65K | 12.46%64.05K | -3.61%-373K | -25.47%-4.83M | ---4.54M | --14.05K | --56.95K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 80.70%-72K | -100.55%-525.12K | -100.03%-33.12K | -18.18%-65K | 24.62%-54.17K | -3.61%-373K | 25.20%95.18M | 25.59%95.66M | -19.57%-55K | -13.73%-71.86K |
| Net cash flow | ||||||||||
| Beginning cash position | -58.34%67.41M | 31.09%161.79M | -3.11%92.45M | -28.77%73.89M | 9.26%120.34M | 31.09%161.79M | 54.28%123.42M | 72.85%95.41M | 51.71%103.74M | 48.96%110.14M |
| Current changes in cash | 139.51%16.35M | -357.01%-101.11M | -138.71%-26.38M | 266.81%16.02M | -777.00%-50.41M | -205.28%-41.38M | -3.06%39.34M | -0.22%68.15M | 32.45%-9.6M | -1.19%-5.75M |
| Effect of exchange rate changes | -375.00%-342K | 795.04%6.73M | 175.71%1.34M | 99.14%2.55M | 699.25%3.96M | -125.81%-72K | -134.09%-967.73K | -2,086.48%-1.77M | 23.31%1.28M | -676.07%-660.32K |
| End cash Position | -30.69%83.41M | -58.34%67.41M | -58.34%67.41M | -3.11%92.45M | -28.77%73.89M | 9.26%120.34M | 31.09%161.79M | 31.09%161.79M | 72.85%95.41M | 51.71%103.73M |
| Free cash from | -121.57%-19.04M | -74.31%-62.32M | -141.63%-18.22M | -70.73%-16.26M | -261.15%-20.19M | 34.86%-8.59M | -0.89%-35.75M | 4.06%-7.54M | 32.77%-9.53M | 0.77%-5.59M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |